Lediana Goduni, MD
Retina Specialist · Beachwood, OHNPI 1366897621
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Regeneron at 41.9% of the total. Reporting peaked in 2024 at $4,957 and has fallen 75.6% since, to $1,209 in 2025.
Across 131 payments — averaging $71.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$4K
- Regeneron Healthcare Solutions, Inc.$1K
- Genentech USA, Inc.$1K
- Alimera Sciences, Inc.$677
- Dutch Ophthalmic, USA$517
- AbbVie$440
- plus $1K from 12 others
Across 3 payments — averaging $1753.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$5K
What the payments were for
- Consulting fees$3,62039%
- Speaking & faculty fees$3504%
- Food & beverage$5,37858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 5 | $3,913 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,310 |
| Genentech USA, Inc. | 17 | $1,066 |
| Alimera Sciences, Inc. | 12 | $677 |
| Dutch Ophthalmic, USA | 5 | $517 |
| AbbVie | 14 | $440 |
| Apellis Pharmaceuticals, Inc. | 13 | $340 |
| Alcon | 3 | $284 |
| Coherus Oncology, Inc. | 3 | $180 |
| Astellas Pharma US Inc | 6 | $166 |
| Eyepoint US, Inc. | 1 | $128 |
| Biogen | 1 | $122 |
| ANI Pharmaceuticals, Inc. | 3 | $62 |
| Bausch & Lomb Americas Inc. | 2 | $45 |
| Carl Zeiss Meditec USA, Inc. | 1 | $30 |
| Sandoz | 1 | $28 |
| Baudax Bio Inc. | 1 | $23 |
| Oyster Point Pharma, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EYLEA HD$4,126
- Iluvien$475
- VABYSMO$419
- EVA, combined machine$398
- TISSUEBLUE$398
- EYLEA$356
- SUSVIMO$282
- OCREVUS$157
- Lucentis$138
- Cimerli$135
- YUTIQ$128
- Vumerity$122
- Constellation$120
- OZURDEX$115
- AcrySof IQ PanOptix$106
How this compares
$9,348 in reported general payments places this provider in the 65th percentile of 69 retina specialist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 163 | $4,323 |
| Difluprednate | 17 | $1,302 |
| Ofloxacin | 118 | $1,001 |
| Brimonidine Tartrate | 27 | $875 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 33 | $683 |
| Ketorolac Tromethamine | 22 | $332 |
| Latanoprost | 33 | $259 |
| Timolol Maleate | 12 | $102 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Beachwood
- Joseph ConeyBeachwood$980K
- David MillerBeachwood$299K
- Michael NovakBeachwood$71K
- Scott PendergastBeachwood$66K
- Llewelyn RaoBeachwood$58K
- Jerome SchartmanBeachwood$30K
- Sean PlattBeachwood$23K
- Shawn LewisBeachwood$7K
- David ShiehBeachwood$3K
- Hernando ZegarraBeachwood$478
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.